AlphaGrep UK’s Inspire Medical Systems INSP Stock Holding History

AlphaGrep UK’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,774	Closed	-$256K	–	858
2025 Q4	$256K	Buy	+2,774	New	+$265K	0.09%	521

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AlphaGrep UK's INSP Position: Q1 2026 in Review

AlphaGrep UK sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 2,774 shares — an estimated $256K sold.

AlphaGrep UK first reported a position in INSP in Q4 2025 and held it in 1 quarter. The position peaked at $256K in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

AlphaGrep UK reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK sold 2,774 Inspire Medical Systems shares in Q1 2026, an estimated $256K.
AlphaGrep UK first reported a position in Inspire Medical Systems in Q4 2025 and held it in 1 quarter.
AlphaGrep UK's Inspire Medical Systems position peaked at $256K in Q4 2025.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on AlphaGrep UK's 13F filing for Q1 2026, filed 13 Aug 2026.